Opendata, web and dolomites

ONco-Energetics_OFF SIGNED

Dissection of Bioenergetic Plasticity of Tumors

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "ONco-Energetics_OFF" data sheet

The following table provides information about the project.

Coordinator
TECHNISCHE UNIVERSITAET DRESDEN 

Organization address
address: HELMHOLTZSTRASSE 10
city: DRESDEN
postcode: 1069
website: http://www.tu-dresden.de/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙499˙875 €
 EC max contribution 1˙499˙875 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2019-STG
 Funding Scheme ERC-STG
 Starting year 2020
 Duration (year-month-day) from 2020-03-01   to  2025-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TECHNISCHE UNIVERSITAET DRESDEN DE (DRESDEN) coordinator 1˙499˙875.00

Map

 Project objective

Tumors reprogram their metabolism to fuel rapid growth. Glycolysis and oxidative phosphorylation “OXPHOS” are the main energy-producing pathways. For decades, metabolic reprogramming of tumors was perceived as only increased glycolysis (Warburg effect). This dogma has recently been revised as we started to realize the importance of OXPHOS in tumor metabolism. We are now entering a new era as metabolomics studies show that tumor metabolism is more heterogeneous than initially assumed. In the preparatory phase of this proposal, using an integrated transcriptional and metabolic profiling, a panel of cancer cell lines was first classified according to the bioenergetic pathway they predominantly utilize (glycolysis or OXPHOS). Second, the response of glycolytic and OXPHOS-dependent cells to the inhibition of their wired bioenergetic program was assessed. My findings show that regardless of their dependency at baseline, cancer cells can be collectively categorized according to their adaptability into “bioenergetically-committed” to one of the two pathways or “bioenergetically-plastic” cells which are able to switch from one to the other upon metabolic challenges. This proposal uses an integrated system approach to dissect the molecular signature, regulation and implications of bioenergetic plasticity. We will answer three key questions: 1-Why some cancer cells are bioenergetically-plastic while others are committed? What are the differences in metabolic machineries and oncogenic switches between both? 2-How heterogeneous tumor cell subpopulations are in terms of bioenergetic plasticity? Does metabolic crosstalk contribute to bioenergetic plasticity of tumors? 3-What are the implications of bioenergetic plasticity in drug resistance and metastasis and finally how to design approaches to target this plasticity? Only handful drugs targeting tumor energetics have made it to clinical use. ONco-Energetics_OFF has a realistic and immediate translational potential.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ONCO-ENERGETICS_OFF" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ONCO-ENERGETICS_OFF" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

NanoPD_P (2020)

High throughput multiplexed trace-analyte screening for diagnostics applications

Read More  

FuncMAB (2019)

High-throughput single-cell phenotypic analysis of functional antibody repertoires

Read More  

NEUROPRECISE (2019)

Precision medicine in traumatic brain injury using individual neurosteroid response

Read More